Verano Holdings (VRNO) Depreciation and Depletion (2021 - 2026)
Verano Holdings (VRNO) reported Depreciation and Depletion of $9.8 million for Q1 2026, up 91.86% year-over-year from $5.1 million in Q1 2025, and down 77.79% quarter-over-quarter from $44.2 million in Q4 2025.
Verano Holdings (VRNO) Depreciation and Depletion (2021 - 2026) Analysis & Trends
Verano Holdings (VRNO) has 6 years of Depreciation and Depletion data on file, last reported at $9.8 million in Q1 2026.
- Depreciation and Depletion for Q1 2026 came in at $9.8 million, up 91.86% year-over-year; the trailing twelve-month figure through Mar 2026 was $73.7 million (up 22.68% YoY), and the FY2025 annual result was $59.2 million, up 8.99% from the prior year.
- Depreciation and Depletion eased to $9.8 million in Q1 2026 per VRNO's latest filing, from $44.2 million in the prior quarter.
- Over five years, Depreciation and Depletion peaked at $44.2 million in Q4 2025 and troughed at -$5.9 million in Q3 2022.
- A 5-year average of $12.9 million and a median of $8.7 million in 2024 frame the typical range for Depreciation and Depletion.
- On a YoY basis, Depreciation and Depletion climbed as much as 307.52% in 2022 and fell as far as 201.66% in 2022.
- A 5-year view of Depreciation and Depletion shows it stood at $31.8 million in 2022, then dropped by 23.63% to $24.3 million in 2023, then soared by 72.06% to $41.8 million in 2024, then climbed by 5.96% to $44.2 million in 2025, then plunged by 77.79% to $9.8 million in 2026.
- Business Quant data shows VRNO's Depreciation and Depletion at $9.8 million in Q1 2026, $44.2 million in Q4 2025, and $9.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 36.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 21.60 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 7.20 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 28.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | - |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | - |
| 10 | Verano Holdings | - | - | 98.98 Mn | 9.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.83 Mn |
| Mar 31, 2026 | 9.83 Mn |
| Dec 31, 2025 | 44.24 Mn |
| Dec 31, 2025 | 44.24 Mn |
| Sep 30, 2025 | 9.89 Mn |
| Sep 30, 2025 | 9.89 Mn |
| Jun 30, 2025 | 9.78 Mn |
| Jun 30, 2025 | 9.78 Mn |
| Mar 31, 2025 | 5.12 Mn |
| Mar 31, 2025 | 5.12 Mn |
| Dec 31, 2024 | 41.75 Mn |
| Dec 31, 2024 | 41.75 Mn |
| Sep 30, 2024 | 4.40 Mn |
| Sep 30, 2024 | 4.40 Mn |
| Jun 30, 2024 | 8.83 Mn |
| Jun 30, 2024 | 8.83 Mn |
| Mar 31, 2024 | 8.72 Mn |
| Mar 31, 2024 | 8.72 Mn |
| Dec 31, 2023 | 24.27 Mn |
| Dec 31, 2023 | 24.27 Mn |